U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT03998709) titled 'Effect of Fasting Free Fatty Acids and Fasting Glucose on 1st and 2nd Phase Insulin Secretion' on June 24.
Brief Summary: Researchers are trying to determine how changes in fasting glucose and free fatty acids (products released from fat) affect insulin secretion.
Study Type: Interventional
Condition: Healthy
Intervention: * Drug: Somatostatin
Somatostatin will be used to inhibit endogenous insulin secretion on either study day in both arms of the study
Other Name: pancreatic clamp
* Other: Dextrose and Intralipid
intravenous glucose and Intralipid will be used to raise fasting FFA and glucose in people with NFG / NGT
Other ...